Skip to content

Effect of extracorporeal shockwave therapy combined with repetitive transcranial magnetic stimulation on spasm of elbow flexor muscles in stroke patients

Effect of extracorporeal shockwave therapy combined with repetitive transcranial magnetic stimulation on spasm of elbow flexor muscles in stroke patients

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500100546
Enrollment
Unknown
Registered
2025-04-10
Start date
2025-03-20
Completion date
Unknown
Last updated
2025-04-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

stroke

Interventions

Experimental group:Transcranial magnetic stimulation combined with extracorporeal shock wave therapy will be performed on the basis of occupational therapy
control group:Pseudo-transcranial magnetic stimulation combined with extracorporeal shock wave therapy will be performed on the basis of occupational therapy

Sponsors

Beijing Haidian Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Meet the diagnostic criteria and classification criteria formulated by the Fourth National Cerebrovascular Academic Conference in 1995, and be diagnosed as stroke by head CT and/or MRI; 2. The first onset, at least 1 month after the onset, unilateral limb paralysis; 3. Age: 18-80 years old; 4. Stable vital signs; 5. Clear consciousness, no serious cognitive dysfunction, can cooperate with treatment; 6. Increased flexor elbow muscle tone, MAS range: 1-3; 7. Signed informed consent form before treatment; 8. No other neurological diseases.

Exclusion criteria

Exclusion criteria: 1. Fracture or severe osteoporosis; 2. Those with severe bleeding tendency or coagulation dysfunction; 3. There are metal implants and pacemakers in the body; 4. Those who have severe cognitive dysfunction or communication disorder and are unable to cooperate; 5. Patients who have received antispasmodic treatment such as botulinum toxin type A injection and/or oral anticonvulsant drugs and surgery in the upper limb within half a year; 6. skull defect; 7. Skin lesions of the upper limbs on the affected side; 8. Pregnancy, brain tumor, meningitis, epilepsy, severe heart, liver, lung, kidney insufficiency, etc.

Design outcomes

Primary

MeasureTime frame
Elbow flexor muscle tone;

Secondary

MeasureTime frame
Upper limb motor function;pain;activity of daily life ;quality of life;

Countries

China

Contacts

Public ContactGao Yang

Beijing Haidian Hospital

945188288@qq.com+86 188 1176 7006

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026